Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients.
Journal of clinical pharmacy and therapeutics 2014 Dec 39 (6): 685-90.
Au A, Baba A A, Azlan H, Norsa'adah B, Ankathil
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: